港股異動 | 呷哺呷哺(0520.HK)漲逾5% 投行看高公司股價至18.2港元
格隆匯11月10日丨呷哺呷哺(0520.HK)股價繼續走強,盤中最高見15.88港元再度刷新自2018年8月份以來新高,現報15.74港元,漲幅5.5%,最新總市值170.3億港元;該股年內已累計漲逾55%。花旗研報指,公司餐廳在十一黃金週期間的同店銷售跌幅收窄至低單位數,旗下品牌餐廳“湊湊”的同店銷售更由9月的下跌低單位數,轉至在10月底錄得增長。將公司目標價由13.1港元升至18.2港元,評級維持“買入”,並預期集團在明年的同店銷售可恢復至去年水平。另外由於新餐廳額外的銷售貢獻,估計集團明年的銷售可較去年水平增長45%。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.